Opioid Ligands Having Delayed Long-Term Antagonist Activity: Potential Pharmacotherapies for Opioid Abuse

Author(s): Stephen M. Husbands, John W. Lewis

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 3 , Issue 2 , 2003

Become EABM
Become Reviewer
Call for Editor


Buprenorphine is a partial agonist at the μ-opioid receptor with long duration of action and also exhibits delayed antagonist activity. Buprenorphine is finding increasing use as a treatment agent for opioid abuse, though its low efficacy is not well tolerated by all addicts. There is interest in developing a higher efficacy version of buprenorphine and in this mini-review some of the ligands recently discovered, that share with buprenorphine a profile of agonism followed by delayed antagonism, are discussed.

Keywords: opioid ligands, long-term antagonistic activity, opioid abuse, buprenorphine, methadone

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2003
Page: [137 - 144]
Pages: 8
DOI: 10.2174/1389557033405395
Price: $65

Article Metrics

PDF: 6